NLRP3 and major depressive disorder: Clinical studies also reported that serum IL-1β, IL-18, NLRP3 and caspase-1 expression in MDD patients was significantly increased, but after antidepressant treatment, indicators were significantly decreased, thereby effectively improving depressive states in patients (Refs 167,168).